메뉴 건너뛰기




Volumn 13, Issue 11, 2013, Pages

Association of IL28B polymorphisms with the response to peginterferon plus ribavirin combined therapy in polish patients infected with HCV Genotype 1 and 4

Author keywords

Hepacivirus; Human; IL28B Protein; Interferon alpha; Polymorphism; Single Nucleotide

Indexed keywords

ALANINE AMINOTRANSFERASE; INTERLEUKIN 28B; PEGINTERFERON; RIBAVIRIN; VIRUS RNA;

EID: 84888601761     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/hepatmon.13678     Document Type: Article
Times cited : (17)

References (28)
  • 1
    • 59149085501 scopus 로고    scopus 로고
    • The global burden of hepatitis C
    • Lavanchy D. The global burden of hepatitis C. Liver Int. 2009;29 Suppl 1:74-81.
    • (2009) Liver Int. , vol.29 , Issue.SUPPL. 1 , pp. 74-81
    • Lavanchy, D.1
  • 2
    • 79958748633 scopus 로고    scopus 로고
    • A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel
    • Cornberg M, Razavi HA, Alberti A, Bernasconi E, Buti M, Cooper C, et al. A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel. Liver Int. 2011;31 Suppl 2:30-60.
    • (2011) Liver Int. , vol.31 , Issue.SUPPL. 2 , pp. 30-60
    • Cornberg, M.1    Razavi, H.A.2    Alberti, A.3    Bernasconi, E.4    Buti, M.5    Cooper, C.6
  • 4
    • 78650766355 scopus 로고    scopus 로고
    • Hepatitis C virus: How genetic variability affects pathobiology of disease
    • Chayama K, Hayes CN. Hepatitis C virus: How genetic variability affects pathobiology of disease. J Gastroenterol Hepatol. 2011;26 Suppl 1:83-95.
    • (2011) J Gastroenterol Hepatol. , vol.26 , Issue.SUPPL. 1 , pp. 83-95
    • Chayama, K.1    Hayes, C.N.2
  • 5
    • 33747797031 scopus 로고    scopus 로고
    • Treating viral hepatitis C: Efficacy, side effects, and complications
    • Manns MP, Wedemeyer H, Cornberg M. Treating viral hepatitis C: efficacy, side effects, and complications. Gut. 2006;55(9):1350-9.
    • (2006) Gut. , vol.55 , Issue.9 , pp. 1350-1359
    • Manns, M.P.1    Wedemeyer, H.2    Cornberg, M.3
  • 6
    • 78349285127 scopus 로고    scopus 로고
    • Hepatitis C: Viral and host factors associated with non-response to pegylated interferon plus ribavirin
    • Asselah T, Estrabaud E, Bieche I, Lapalus M, De Muynck S, Vidaud M, et al. Hepatitis C: viral and host factors associated with non-response to pegylated interferon plus ribavirin. Liver Int. 2010;30(9):1259-69.
    • (2010) Liver Int. , vol.30 , Issue.9 , pp. 1259-1269
    • Asselah, T.1    Estrabaud, E.2    Bieche, I.3    Lapalus, M.4    De Muynck, S.5    Vidaud, M.6
  • 7
    • 58149380829 scopus 로고    scopus 로고
    • Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients using viral and host factors
    • Shirakawa H, Matsumoto A, Joshita S, Komatsu M, Tanaka N, Umemura T, et al. Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients using viral and host factors. Hepatology. 2008;48(6):1753-60.
    • (2008) Hepatology. , vol.48 , Issue.6 , pp. 1753-1760
    • Shirakawa, H.1    Matsumoto, A.2    Joshita, S.3    Komatsu, M.4    Tanaka, N.5    Umemura, T.6
  • 8
    • 70349533037 scopus 로고    scopus 로고
    • Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C
    • Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N, et al. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet. 2009;41(10):1105-9.
    • (2009) Nat Genet. , vol.41 , Issue.10 , pp. 1105-1109
    • Tanaka, Y.1    Nishida, N.2    Sugiyama, M.3    Kurosaki, M.4    Matsuura, K.5    Sakamoto, N.6
  • 9
    • 70349548852 scopus 로고    scopus 로고
    • IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy
    • Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, Abate ML, et al. IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet. 2009;41(10):1100-4.
    • (2009) Nat Genet. , vol.41 , Issue.10 , pp. 1100-1104
    • Suppiah, V.1    Moldovan, M.2    Ahlenstiel, G.3    Berg, T.4    Weltman, M.5    Abate, M.L.6
  • 10
    • 77949831342 scopus 로고    scopus 로고
    • Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: A genome-wide association study
    • 1338-45-45+e1-e7
    • Rauch A, Kutalik Z, Descombes P, Cai T, Di Iulio J, Mueller T, et al. Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology. 2010;138(4):1338-45-45 e1-7.
    • (2010) Gastroenterology. , vol.138 , Issue.4
    • Rauch, A.1    Kutalik, Z.2    Descombes, P.3    Cai, T.4    Di Iulio, J.5    Mueller, T.6
  • 11
    • 70349292099 scopus 로고    scopus 로고
    • Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
    • Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature. 2009;461(7262):399-401.
    • (2009) Nature. , vol.461 , Issue.7262 , pp. 399-401
    • Ge, D.1    Fellay, J.2    Thompson, A.J.3    Simon, J.S.4    Shianna, K.V.5    Urban, T.J.6
  • 12
    • 70349966196 scopus 로고    scopus 로고
    • Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
    • Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O'Huigin C, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature. 2009;461(7265):798-801.
    • (2009) Nature. , vol.461 , Issue.7265 , pp. 798-801
    • Thomas, D.L.1    Thio, C.L.2    Martin, M.P.3    Qi, Y.4    Ge, D.5    O'Huigin, C.6
  • 13
    • 0026458517 scopus 로고
    • A non-organic and non-enzymatic extraction method gives higher yields of genomic DNA from whole-blood samples than do nine other methods tested
    • Lahiri DK, Bye S, Nurnberger JI, Jr, Hodes ME, Crisp M. A non-organic and non-enzymatic extraction method gives higher yields of genomic DNA from whole-blood samples than do nine other methods tested. J Biochem Biophys Methods. 1992;25(4):193-205.
    • (1992) J Biochem Biophys Methods. , vol.25 , Issue.4 , pp. 193-205
    • Lahiri, D.K.1    Bye, S.2    Nurnberger Jr., J.I.3    Hodes, M.E.4    Crisp, M.5
  • 14
    • 84878239932 scopus 로고    scopus 로고
    • Impact of IL-28B polymorphisms on pegylated interferon plus ribavirin treatment response in children and adolescents infected with HCV genotypes 1 and 4
    • Domagalski K, Pawlowska M, Tretyn A, Halota W, Pilarczyk M, Smukalska E, et al. Impact of IL-28B polymorphisms on pegylated interferon plus ribavirin treatment response in children and adolescents infected with HCV genotypes 1 and 4. Eur J Clin Microbiol Infect Dis. 2013;32(6):745-54.
    • (2013) Eur J Clin Microbiol Infect Dis. , vol.32 , Issue.6 , pp. 745-754
    • Domagalski, K.1    Pawlowska, M.2    Tretyn, A.3    Halota, W.4    Pilarczyk, M.5    Smukalska, E.6
  • 16
    • 77952693487 scopus 로고    scopus 로고
    • Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin
    • McCarthy JJ, Li JH, Thompson A, Suchindran S, Lao XQ, Patel K, et al. Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin. Gastroenterology. 2010;138(7):2307-14.
    • (2010) Gastroenterology. , vol.138 , Issue.7 , pp. 2307-2314
    • McCarthy, J.J.1    Li, J.H.2    Thompson, A.3    Suchindran, S.4    Lao, X.Q.5    Patel, K.6
  • 17
    • 79952899824 scopus 로고    scopus 로고
    • Impact of IL28B genotype on the early and sustained virologic response in treatment-naive patients with chronic hepatitis C
    • 344-50e2
    • Stattermayer AF, Stauber R, Hofer H, Rutter K, Beinhardt S, Scherzer TM, et al. Impact of IL28B genotype on the early and sustained virologic response in treatment-naive patients with chronic hepatitis C. Clin Gastroenterol Hepatol. 2011;9(4):344-50 e2.
    • (2011) Clin Gastroenterol Hepatol. , vol.9 , Issue.4
    • Stattermayer, A.F.1    Stauber, R.2    Hofer, H.3    Rutter, K.4    Beinhardt, S.5    Scherzer, T.M.6
  • 18
    • 84858134441 scopus 로고    scopus 로고
    • The importance of IL28B polymorphism in response to pegylated interferon α and ribavirin in chronic hepatitis caused by HCV genotype 1b
    • Mach T, Ciesla A, Sanak M, Glowacki MK, Warunek W, Owczarek D. The importance of IL28B polymorphism in response to pegylated interferon α and ribavirin in chronic hepatitis caused by HCV genotype 1b. Prz Gastroenterol. 2012;7(1):38-42.
    • (2012) Prz Gastroenterol. , vol.7 , Issue.1 , pp. 38-42
    • Mach, T.1    Ciesla, A.2    Sanak, M.3    Glowacki, M.K.4    Warunek, W.5    Owczarek, D.6
  • 19
    • 84871855792 scopus 로고    scopus 로고
    • The occurrence of HCV genotypes and single polynucleotide polymorphisms of rs12979860 among HCV infected patients in northeastern Poland
    • Kozlowski P, Pogorzelska J, Lapinski TW, Kowalczuk O, Niklinski J, Flisiak R. [The occurrence of HCV genotypes and single polynucleotide polymorphisms of rs12979860 among HCV infected patients in northeastern Poland]. Przegl Epidemiol. 2012;66(2):335-9.
    • (2012) Przegl Epidemiol. , vol.66 , Issue.2 , pp. 335-339
    • Kozlowski, P.1    Pogorzelska, J.2    Lapinski, T.W.3    Kowalczuk, O.4    Niklinski, J.5    Flisiak, R.6
  • 20
    • 80052660473 scopus 로고    scopus 로고
    • A single IL28B genotype SNP rs12979860 determination predicts treatment response in patients with chronic hepatitis C Genotype 1 virus
    • Halfon P, Bourliere M, Ouzan D, Maor Y, Renou C, Wartelle C, et al. A single IL28B genotype SNP rs12979860 determination predicts treatment response in patients with chronic hepatitis C Genotype 1 virus. Eur J Gastroenterol Hepatol. 2011;23(10):931-5.
    • (2011) Eur J Gastroenterol Hepatol. , vol.23 , Issue.10 , pp. 931-935
    • Halfon, P.1    Bourliere, M.2    Ouzan, D.3    Maor, Y.4    Renou, C.5    Wartelle, C.6
  • 21
    • 84871976557 scopus 로고    scopus 로고
    • Meta-analysis: Implications of interleukin-28B polymorphisms in spontaneous and treatment-related clearance for patients with hepatitis C
    • Jimenez-Sousa MA, Fernandez-Rodriguez A, Guzman-Fulgencio M, Garcia-Alvarez M, Resino S. Meta-analysis: implications of interleukin-28B polymorphisms in spontaneous and treatment-related clearance for patients with hepatitis C. BMC Med. 2013;11:6.
    • (2013) BMC Med. , vol.11 , pp. 6
    • Jimenez-Sousa, M.A.1    Fernandez-Rodriguez, A.2    Guzman-Fulgencio, M.3    Garcia-Alvarez, M.4    Resino, S.5
  • 22
    • 84856189254 scopus 로고    scopus 로고
    • Host genomics and HCV treatment response
    • Clark PJ, Thompson AJ. Host genomics and HCV treatment response. J Gastroenterol Hepatol. 2012;27(2):212-22.
    • (2012) J Gastroenterol Hepatol. , vol.27 , Issue.2 , pp. 212-222
    • Clark, P.J.1    Thompson, A.J.2
  • 23
    • 80055047790 scopus 로고    scopus 로고
    • Impact of IL28B on treatment outcome in hepatitis C virus G1/4 patients receiving response-guided therapy with peginterferon alpha-2a (40KD)/ribavirin
    • Scherzer TM, Stattermayer AF, Strasser M, Laferl H, Maieron A, Stauber R, et al. Impact of IL28B on treatment outcome in hepatitis C virus G1/4 patients receiving response-guided therapy with peginterferon alpha-2a (40KD)/ribavirin. Hepatology. 2011;54(5):1518-26.
    • (2011) Hepatology. , vol.54 , Issue.5 , pp. 1518-1526
    • Scherzer, T.M.1    Stattermayer, A.F.2    Strasser, M.3    Laferl, H.4    Maieron, A.5    Stauber, R.6
  • 24
    • 84984584308 scopus 로고    scopus 로고
    • Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin
    • Liu CH, Liang CC, Liu CJ, Tseng TC, Lin CL, Yang SS, et al. Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin. Antivir Ther. 2012;17(6):1059-67.
    • (2012) Antivir Ther. , vol.17 , Issue.6 , pp. 1059-1067
    • Liu, C.H.1    Liang, C.C.2    Liu, C.J.3    Tseng, T.C.4    Lin, C.L.5    Yang, S.S.6
  • 25
    • 79960382329 scopus 로고    scopus 로고
    • IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C
    • Bochud PY, Bibert S, Negro F, Haagmans B, Soulier A, Ferrari C, et al. IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C. J Hepatol. 2011;55(5):980-8.
    • (2011) J Hepatol. , vol.55 , Issue.5 , pp. 980-988
    • Bochud, P.Y.1    Bibert, S.2    Negro, F.3    Haagmans, B.4    Soulier, A.5    Ferrari, C.6
  • 26
    • 77953881002 scopus 로고    scopus 로고
    • Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus
    • 120-9e18
    • Thompson AJ, Muir AJ, Sulkowski MS, Ge D, Fellay J, Shianna KV, et al. Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus. Gastroenterology. 2010;139(1):120-9 e18.
    • (2010) Gastroenterology. , vol.139 , Issue.1
    • Thompson, A.J.1    Muir, A.J.2    Sulkowski, M.S.3    Ge, D.4    Fellay, J.5    Shianna, K.V.6
  • 27
    • 84873707575 scopus 로고    scopus 로고
    • Sustained virologic response and IL28B single-nucleotide polymorphisms in patients with chronic hepatitis C treated with pegylated interferon alfa and ribavirin
    • Jablonowska E, Piekarska A, Koslinska-Berkan E, Omulecka A, Szymanska B, Wojcik K. Sustained virologic response and IL28B single-nucleotide polymorphisms in patients with chronic hepatitis C treated with pegylated interferon alfa and ribavirin. Acta Biochim Pol. 2012;59(3):333-7.
    • (2012) Acta Biochim Pol. , vol.59 , Issue.3 , pp. 333-337
    • Jablonowska, E.1    Piekarska, A.2    Koslinska-Berkan, E.3    Omulecka, A.4    Szymanska, B.5    Wojcik, K.6
  • 28
    • 78049465963 scopus 로고    scopus 로고
    • A model explaining the correlations between IL28B-related genotypes, hepatitis C virus genotypes, and viral RNA levels
    • Lindh M, Lagging M, Norkrans G, Hellstrand K. A model explaining the correlations between IL28B-related genotypes, hepatitis C virus genotypes, and viral RNA levels. Gastroenterology. 2010;139(5):1794-6.
    • (2010) Gastroenterology. , vol.139 , Issue.5 , pp. 1794-1796
    • Lindh, M.1    Lagging, M.2    Norkrans, G.3    Hellstrand, K.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.